ong term efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea.

Phase 4

Recruiting

• Conditions: Obstructive sleep apnea; PAP adherence; Intranasal corticosteroid; Continuous Positive Airway Pressure

• Registration Number: TCTR20220517004
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-17
• Study Completion: 2022-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 116

Inclusion Criteria

1. New patients who are diagnosed as Obstructive sleep apnea and benefit form CPAP device use according to physician decision in Thammasat hospital., 2. Patient can use CPAP device at home, 3. Age 18 to 70 years old, 4. Patient who first visit at Thammasat hospital since January 2022, 5. Pateints who had been registered to study Efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea.

Exclusion Criteria

1. Impair cognitive function, 2. Already used intranasal steroid, 3. Have others sleep problems such as Nacrolepsy, Insomnia, Parasomnia or Central sleep apnea. 4. Allergy to Azelastine HCl and Fluticasone proprionate, 5. Could not reading and writing

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adherence to CPAP used at 12 months after end of the intervention day of CPAP used

Secondary Outcome Measures

Name	Time	Method
asal symptoms 12 months after use intranasal steroid TNSS score